Announced Tue, 18 Aug · 11:15 IST
Thyrocare promoter Docon's pledge on 7.94 crore shares fully released
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.5%1-day move
₹620.00
prior close
₹609.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.1-6.5-8.5-8.7———————
Up moveDown movePending
AI summary
Promoter Docon's pledge over 7,94,69,696 Thyrocare shares (49.93% of share capital) has been fully released. This followed API Holdings' full repayment of NCDs worth INR 10,500 million on August 14, 2026. The repayment was funded partly via Docon's sale of 1,57,69,696 Thyrocare shares (around 9.9%). Docon's entire holding of 8,12,00,000 shares (51.02%) is now free from any encumbrance.
Likely market impact
Positive for Thyrocare: Promoter's entire 51% stake is now unencumbered, reducing forced-sale risk and showing API Holdings has cleared its debt.